MolNFT v1 · #15695 · protein
Structure of the antitumor protein-chromophore complex neocarzinostatin
1NCO · Holo-neocarzinostatin: “Structure of the antitumor protein-chromophore complex neocarzinostatin”. X-ray diffraction, 1 ligand (CHR), 3 pockets (best druggability 0.64). MolNFT v1 #15695 on GenesisL1: 3D structure, binding sites and…
- PDB
- 1NCO
- Type
- protein
- Length
- 226 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Holo-neocarzinostatin
- UniProt
- P0A3R9
- Ligands
- CHR
- Pockets
- 3 · best druggability 0.64
Structure
x-ray diffraction · 1 distinct chain · 3% helix, 51% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Holo-neocarzinostatin | protein | 113 | 3% helix, 51% strand | P0A3R9 |
Ligands and binding sites
- CHR · Neocarzinostatin-chromophore · ligand · chains A, B
- MRD · (4R)-2-methylpentane-2,4-diol · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 95 | 0.64 | 0.90 | 22 | empty |
| 2 | 233 | 0.56 | 0.78 | 29 | CHR |
| 3 | 131 | 0.48 | 0.78 | 24 | MRD |
Interfaces
1 interface between chains.
- A–B · 427 Ų buried · 12 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 4 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0A3R9
- Elsewhere: RCSB PDB 1NCO · PDBe 1NCO · UniProt P0A3R9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.